Carmit Nadri-Shay
Conseiller Juridique Général chez ADVAXIS, INC.
Postes actifs de Carmit Nadri-Shay
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADVAXIS, INC. | Conseiller Juridique Général | - | - |
| AYALA PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2018 | - |
Historique de carrière de Carmit Nadri-Shay
Anciens postes connus de Carmit Nadri-Shay
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Conseiller Juridique Général | - | - |
| KAMADA LTD. | Conseiller Juridique Général | - | - |
Formation de Carmit Nadri-Shay
| Ben-Gurion University of the Negev | Doctorate Degree |
Statistiques
Internationale
| Israël | 5 |
| Etats-Unis | 2 |
Opérationnelle
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KAMADA LTD. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Bourse
- Insiders
- Carmit Nadri-Shay
- Expérience